Market Cap 19.15B
Revenue (ttm) 2.76B
Net Income (ttm) -1.03B
EPS (ttm) N/A
PE Ratio 532.26
Forward PE 378.06
Profit Margin -37.29%
Debt to Equity Ratio 0.00
Volume 6,629,200
Avg Vol 5,667,934
Day's Range N/A - N/A
Shares Out 189.47M
Stochastic %K 20%
Beta 1.42
Analysts Sell
Price Target $97.88

Company Profile

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic,...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 608 284 5700
Address:
5505 Endeavor Lane, Madison, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:19 AM
Actionable Trade Alert for $EXAS: Market Context: $EXAS is currently trading at $101.13, close to its 60D high of $101.87, indicating potential resistance. The RSI at 96.93 suggests the stock is overbought, which may lead to a pullback. However, the strong performance above the MA30 (78.6) and MA50 (70.55) indicates bullish momentum. Directional Bias: Given the high RSI and proximity to the 60D high, expect a short-term pullback followed by a potential continuation of the uptrend if it breaks above resistance. Trade Plan: - Suggested Entry: $100.00 (anticipating a slight pullback) - Stop Loss: $95.00 (5% below entry) - Take Profit Targets: 1. $105.00 (5% gain) 2. $110.00 (10% gain) 3. $118.00 (17% gain) This plan allows for a solid risk-reward ratio with a potential ROI of over 17% on the final target. Monitor closely for any changes in momentum. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 9:54 PM
Actionable Trade Alert for $EXAS: Market Context: $EXAS is currently trading at $101.13, close to its 60D high of $101.87, indicating potential resistance. The RSI at 96.93 suggests the stock is overbought, which may lead to a pullback. However, the strong performance above the MA30 (78.6) and MA50 (70.55) indicates bullish momentum. Directional Bias: Given the high RSI and proximity to the 60D high, expect a short-term pullback followed by a potential continuation of the uptrend if it breaks above resistance. Trade Plan: - Suggested Entry: $100.00 (anticipating a slight pullback) - Stop Loss: $95.00 (5% below entry) - Take Profit Targets: 1. $105.00 (5% gain) 2. $110.00 (10% gain) 3. $118.00 (17% gain) This plan allows for a solid risk-reward ratio with a potential ROI of over 17% on the final target. Monitor closely for any changes in momentum. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 5 at 10:30 AM
$EXAS RSI: 96.93, MACD: 10.2499 Vol: 16.81, MA20: 85.24, MA50: 70.55 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
stockanalysis_
stockanalysis_ Dec. 5 at 1:07 AM
Overbought Stocks: $MAGH $SND $HAE $EXAS $CDTX View the entire list here: https://stockanalysis.com/list/overbought-stocks/?ref=saveontrading
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 7:17 AM
Hedge Alert Live - Protect Your Portfolio Contract: $EXAS $100.00 Put · DEC 19, 2025 Exp Entry Price: $0.09 - $0.25 Exit Price Target: $0.13 Profit Margin: +43% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Kool_Aid_Mann
Kool_Aid_Mann Dec. 4 at 12:05 AM
$LUCD I bought almost all of my shares of $EXAS under $4, and the great majority under $2. My biggest mistake was selling far, far too early at around $19. I thought I had made out very well, but, in hindsight, left so much on the table. Had I continued to hold just 5 more years, EXAS would have turned from a 6 bagger to a 50 bagger. $LUCD is where $EXAS was in 2015-2016, but with a lot more potential and, currently, a lot cheaper than EXAS was. I won't make the same mistake selling the core of LUCD off too early. I expect it to run through the $2 's in the next 6 months and then up to $8-10 in the two years following that. I do plan to sell a small amount of my almost 300k shares after 10, but the majority I will hold through the commercial growth. IF we dont get bought out before then. My target for about 200k of those shares will be $100 (in a decade or so). In the word of Axl Rose, 'All we need is just a little patience'.
2 · Reply
Estimize
Estimize Dec. 3 at 3:09 PM
Wall St is expecting -0.08 EPS for $EXAS Q4 [Reporting 02/24 AMC] http://www.estimize.com/intro/exas?chart=historical&metric_name=eps&utm_c
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 11:01 AM
$EXAS Current Stock Price: $101.18 Contracts to trade: $100 EXAS Dec 19 2025 Call Entry: $1.48 Exit: $2.25 ROI: 51% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 7:03 PM
Stifel has adjusted their stance on Exact Sciences ( $EXAS ), setting the rating to Hold with a target price of 80 → 105.
0 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 6:58 PM
Stifel updates rating for Exact Sciences ( $EXAS ) to Buy, target set at 85.
0 · Reply
Latest News on EXAS
Top 2 Health Care Stocks You May Want To Dump This Month

Dec 2, 2025, 9:01 AM EST - 5 days ago

Top 2 Health Care Stocks You May Want To Dump This Month

HAE


Exact Sciences Corporation (EXAS) M&A Call Transcript

Nov 20, 2025, 5:03 PM EST - 16 days ago

Exact Sciences Corporation (EXAS) M&A Call Transcript


Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More

Nov 20, 2025, 4:44 PM EST - 16 days ago

Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More

BBWI PACS SNDK


Why Exact Sciences Rallied Over 50% This Week

Nov 20, 2025, 3:31 PM EST - 16 days ago

Why Exact Sciences Rallied Over 50% This Week


Why Exact Sciences Stock Surged Today

Nov 20, 2025, 3:01 PM EST - 16 days ago

Why Exact Sciences Stock Surged Today


Abbott to Acquire Exact Sciences for $21 Billion

Nov 20, 2025, 7:46 AM EST - 17 days ago

Abbott to Acquire Exact Sciences for $21 Billion

ABT


Why Exact Sciences Stock Blasted Nearly 24% Higher Today

Nov 19, 2025, 7:21 PM EST - 17 days ago

Why Exact Sciences Stock Blasted Nearly 24% Higher Today


Why Exact Sciences Stock Blasted Higher on Tuesday

Nov 4, 2025, 8:05 PM EST - 4 weeks ago

Why Exact Sciences Stock Blasted Higher on Tuesday


Exact Sciences to Participate in November Investor Conference

Nov 4, 2025, 7:00 AM EST - 4 weeks ago

Exact Sciences to Participate in November Investor Conference


Exact Sciences Announces Third Quarter 2025 Results

Nov 3, 2025, 4:05 PM EST - 4 weeks ago

Exact Sciences Announces Third Quarter 2025 Results


Should You Buy Exact Sciences Stock Before Nov. 3?

Nov 2, 2025, 6:53 AM EST - 5 weeks ago

Should You Buy Exact Sciences Stock Before Nov. 3?


Exact Sciences Schedules Third Quarter 2025 Earnings Call

Oct 8, 2025, 7:00 AM EDT - 2 months ago

Exact Sciences Schedules Third Quarter 2025 Earnings Call


Exact Sciences' Clear Expansion Path: Why Choose To Buy

Sep 25, 2025, 5:07 AM EDT - 2 months ago

Exact Sciences' Clear Expansion Path: Why Choose To Buy


Exact Sciences CEO on Launch of Multi-Cancer Blood Test

Sep 15, 2025, 3:30 PM EDT - 2 months ago

Exact Sciences CEO on Launch of Multi-Cancer Blood Test


Exact Sciences to Participate in September Investor Conferences

Aug 19, 2025, 6:00 AM EDT - 3 months ago

Exact Sciences to Participate in September Investor Conferences


Exact Sciences (EXAS) Q2 Revenue Up 16%

Aug 6, 2025, 5:13 PM EDT - 4 months ago

Exact Sciences (EXAS) Q2 Revenue Up 16%


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:19 AM
Actionable Trade Alert for $EXAS: Market Context: $EXAS is currently trading at $101.13, close to its 60D high of $101.87, indicating potential resistance. The RSI at 96.93 suggests the stock is overbought, which may lead to a pullback. However, the strong performance above the MA30 (78.6) and MA50 (70.55) indicates bullish momentum. Directional Bias: Given the high RSI and proximity to the 60D high, expect a short-term pullback followed by a potential continuation of the uptrend if it breaks above resistance. Trade Plan: - Suggested Entry: $100.00 (anticipating a slight pullback) - Stop Loss: $95.00 (5% below entry) - Take Profit Targets: 1. $105.00 (5% gain) 2. $110.00 (10% gain) 3. $118.00 (17% gain) This plan allows for a solid risk-reward ratio with a potential ROI of over 17% on the final target. Monitor closely for any changes in momentum. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 9:54 PM
Actionable Trade Alert for $EXAS: Market Context: $EXAS is currently trading at $101.13, close to its 60D high of $101.87, indicating potential resistance. The RSI at 96.93 suggests the stock is overbought, which may lead to a pullback. However, the strong performance above the MA30 (78.6) and MA50 (70.55) indicates bullish momentum. Directional Bias: Given the high RSI and proximity to the 60D high, expect a short-term pullback followed by a potential continuation of the uptrend if it breaks above resistance. Trade Plan: - Suggested Entry: $100.00 (anticipating a slight pullback) - Stop Loss: $95.00 (5% below entry) - Take Profit Targets: 1. $105.00 (5% gain) 2. $110.00 (10% gain) 3. $118.00 (17% gain) This plan allows for a solid risk-reward ratio with a potential ROI of over 17% on the final target. Monitor closely for any changes in momentum. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 5 at 10:30 AM
$EXAS RSI: 96.93, MACD: 10.2499 Vol: 16.81, MA20: 85.24, MA50: 70.55 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
stockanalysis_
stockanalysis_ Dec. 5 at 1:07 AM
Overbought Stocks: $MAGH $SND $HAE $EXAS $CDTX View the entire list here: https://stockanalysis.com/list/overbought-stocks/?ref=saveontrading
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 7:17 AM
Hedge Alert Live - Protect Your Portfolio Contract: $EXAS $100.00 Put · DEC 19, 2025 Exp Entry Price: $0.09 - $0.25 Exit Price Target: $0.13 Profit Margin: +43% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Kool_Aid_Mann
Kool_Aid_Mann Dec. 4 at 12:05 AM
$LUCD I bought almost all of my shares of $EXAS under $4, and the great majority under $2. My biggest mistake was selling far, far too early at around $19. I thought I had made out very well, but, in hindsight, left so much on the table. Had I continued to hold just 5 more years, EXAS would have turned from a 6 bagger to a 50 bagger. $LUCD is where $EXAS was in 2015-2016, but with a lot more potential and, currently, a lot cheaper than EXAS was. I won't make the same mistake selling the core of LUCD off too early. I expect it to run through the $2 's in the next 6 months and then up to $8-10 in the two years following that. I do plan to sell a small amount of my almost 300k shares after 10, but the majority I will hold through the commercial growth. IF we dont get bought out before then. My target for about 200k of those shares will be $100 (in a decade or so). In the word of Axl Rose, 'All we need is just a little patience'.
2 · Reply
Estimize
Estimize Dec. 3 at 3:09 PM
Wall St is expecting -0.08 EPS for $EXAS Q4 [Reporting 02/24 AMC] http://www.estimize.com/intro/exas?chart=historical&metric_name=eps&utm_c
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 11:01 AM
$EXAS Current Stock Price: $101.18 Contracts to trade: $100 EXAS Dec 19 2025 Call Entry: $1.48 Exit: $2.25 ROI: 51% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 7:03 PM
Stifel has adjusted their stance on Exact Sciences ( $EXAS ), setting the rating to Hold with a target price of 80 → 105.
0 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 6:58 PM
Stifel updates rating for Exact Sciences ( $EXAS ) to Buy, target set at 85.
0 · Reply
meatpuppets
meatpuppets Dec. 2 at 5:42 PM
$GRAL $MS 110 pt from morgan $EXAS sold. grail last chance monkey ass.
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 1 at 10:10 PM
Hedge Alert Live - Protect Your Portfolio Contract: $EXAS $100.00 Put · DEC 19, 2025 Exp Entry Price: $0.15 - $0.20 Exit Price Target: $0.26 Profit Margin: +71% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Enjoy_Life_Bro
Enjoy_Life_Bro Dec. 1 at 2:13 AM
$EXAS Do you all think Abbott consolidates and dumps the Madison facilities? How long? It could help with affordability of real estate in Madison.
0 · Reply
SpaceSailor
SpaceSailor Nov. 30 at 5:54 PM
$EXAS bang bang
0 · Reply
julianjakobi
julianjakobi Nov. 27 at 4:51 AM
$BLGO https://www.woundsource.com/product/viaclyr $BLGO – tiny company, massive catalyst on deck. ViaCLYR is an FDA‑cleared, copper‑iodine wound irrigation solution with broad‑spectrum kill, biofilm impact, no known resistance and no‑rinse workflow. It’s exactly what wound clinics and surgeons want in 2025. Clyra has multiple distributors lined up, a nationwide partner targeting thousands of U.S. hospitals, and is guiding a late 2025 / early 2026 commercial launch into a wound irrigation market sized in the hundreds of millions. If execution finally matches the tech and the product gains even modest share, a sub $1 BLGO looks wildly mispriced for a recurring‑revenue consumable riding a multi‑year adoption curve. $EXAS like returns seem possible.
0 · Reply
ABinterceptor
ABinterceptor Nov. 26 at 6:24 PM
$EXAS Question for the experienced traders. I have Jan 26 $100 calls @3.3. The current price is $2.15, at $105 of the underlying the option price should be much higher, but the expiration is in 1.5 month. Should I wait for the option price to go to break-even level or sell at loss?
0 · Reply
KappaKeepoKuppo
KappaKeepoKuppo Nov. 26 at 2:05 PM
$EXAS $ABT It's a bit annoying that this got acquired by a much bigger fish. Feels like EXAS would have caught up narrative wise with competitors in liquid biopsy, MCED and MRD arenas sooner rather than later. Now, it is quite unclear whether the bigger fish is more interested in the poop test or the pipeline. Even if the bigger fish is somewhat interested in the pipeline, it will take ages for that bottom line to be reflected in ABT's market cap percentage wise, I think.
1 · Reply
PMD777
PMD777 Nov. 26 at 1:22 PM
$EXAS remember owning and trading this below the teens...man I suck at biotech picks...
0 · Reply
Fight_the_AI_Machine
Fight_the_AI_Machine Nov. 26 at 3:09 AM
$ROOT $EXAS same thing the MM’s did to EXAS is what’s happening to ROOT… they know the price and offer but until announcement they shake the rug
1 · Reply
HedgeAlerts
HedgeAlerts Nov. 26 at 2:25 AM
Hedge Alert Live - Protect Your Portfolio Contract: $EXAS $100.00 Put · DEC 19, 2025 Exp Entry Price: $0.25 - $0.35 Exit Price Target: $0.42 Profit Margin: +68% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
MWM
MWM Nov. 25 at 5:12 PM
$ALGN looks like a Breakout is underway! Possible Buyout Candidate imo, similar to $EXAS!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 25 at 2:18 PM
$EXAS RSI: 88.32, MACD: 8.6925 Vol: 12.99, MA20: 72.82, MA50: 63.80 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply